Comparison of localized versus systemic levels of Matrix metalloproteinases (MMPs), its tissue inhibitors (TIMPs) and cytokines in tuberculous and non-tuberculous pleuritis patients

Human Immunology

Volumn 73, Issue 10, 2012, Pages 985-991

  Sundararajan, Swetha ^a   Babu, Subash ^b   Das, Sulochana D ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b NATIONAL INSTITUTE OF FASHION TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GELATINASE B; INTERLEUKIN 4; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; PLEURA FLUID; PLEURISY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TUBERCULOUS PLEURISY;

ADOLESCENT; ADULT; CYTOKINES; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PLEURAL EFFUSION; PLEURISY; TISSUE INHIBITOR OF METALLOPROTEINASES; TUBERCULOSIS, PLEURAL; YOUNG ADULT;

EID: 84866353431     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.07.042     Document Type: Article

References (36)

1. Berger H.W., Mejia E. Tuberculous pleurisy. Chest 1973, 63:88-92.
2. Gopi A., Madhavan S.M., Sharma S.K., Sahn S.A. Diagnosis of treatment of tuberculous pleural effusion. Chest 2007, 131:880-889.
3. Elkington P., Shiomi T., Breen R., Nuttal R., Ugarte-Gil C.A., Walker N., et al. MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J Clin Invest 2011, 121:1827-1833.
4. Sheen P., O'Kane C.M., Chaudhary K., Tovar M., Santillan C., Sosa J., et al. High MMP-9 activity characterizes pleural tuberculosis correlating with granuloma formation. Eur Respir J 2009, 33:134-141.
5. Park K.J., Hwang S.C., Sheen S.S., Oh Y.J., Han J.H., Lee K.B. Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer. Respiration 2005, 72:166-175.
6. Lin F.C., Chen Y.C., Chen F.J., Chang S.C. Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions. Clin Immunol 2005, 116:166-173.
7. Taylor J.L., Hattle J.M., Dreitz S.A., Troudt J.M., Izzo L.S., Basaraba R.J., et al. Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect Immun 2006, 74:6135-6144.
8. Eickelberg O., Sommerfeld C.O., Wyser C., Tamm M., Reichenberger F., Bardin P.G., et al. MMP and TIMP expression pattern in pleural effusions of different origins. Am J Respir Crit Care Med 1997, 156:1987-1992.
9. Anand S.P., Selvaraj P. Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis. Clin Immunol 2009, 133:126-131.
10. Hoheisel G., Sack U., Hui D.S., Huse K., Chan K.S., Chan K.K., et al. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis. Tuberculosis 2001, 81:203-209.
11. Iglesias D., Alegre J., Alemán C., Ruíz E., Soriano T., Armadans L.I., et al. Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions. Eur Respir J 2005, 25:104-109.
12. Ma C., Tarnuzzer R.W., Chengini N. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-β1. Wound Repair Regen 1999, 7:477-485.
13. Elkington P.T.G., Nuttall R.K., Boyle J.J., O'Kane C.M., Horncastle D.E., Edwards D.R., et al. Mycobacterium tuberculosis, but not vaccine bcg, specifically upregulates Matrix metalloproteinase-1. Am J Respir Crit Care Med 2005, 172:1596-1604.
14. Dunsmore S.E., Saarialho-Kere U.K., Roby J.D., Wilson C.L., Matrisian L.M., Welgus H.G., Parks W.C. Matrilysin expression and function in airway epithelium. J Clin Invest 1998, 102:1321-1331.
15. Lopez-Boado Y.S., Wilson C.L., Parks W.C. Regulation of Matrilysin expression in airway epithelial cells by Pseudomonas aeruginosa flagellin. J Biol Chem 2001, 276:41417-41423.
16. Sorsa T., Tervahartiala T., Leppilahti J., Hernandez M., Gamonal J., Tuomainen A.M., et al. Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines. Pharmacol Res 2011, 63:108-113.
17. Pussinen PJ, Sarna S, Puolakkainen M, Ohlin H, Sorsa T, Pesonen E. The balance of serum matrix metalloproteinase-8 and its tissue inhibitor in acute coronary syndrome and its recurrence. Int J Cardiol 2012. [Epub ahead of print].
18. Lauhio A., Hästbacka J., Pettilä V., Tervahartiala T., Karlsson S., Varpula T., et al. Serum MMP-8, -9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines. Pharmacol Res 2011, 64:590-594.
19. Quiding-Järbrink M., Smith D.A., Bancroft G.J. Production of matrix metalloproteinases in response to mycobacterial infection. Infect Immun 2001, 69:5661-5670.
20. Hrabec E., Strek M., Zieba M., Kwiatkowska S., Hrabec Z. Circulation level of matrix metalloproteinase-9 is correlated with disease severity in tuberculosis patients. Int J Tuberc Lung Dis 2002, 6:713-719.
21. Koç M., Ediger D., Budak F., Karadaĝ M., Oral H.B., Uzaslan E., et al. Matrix metalloproteinase-9 (MMP-9) elevated in serum but not in bronchial lavage fluid in patients with lung cancer. Tumori 2006, 92:149-154.
22. Zucker S., Cao J. Measurement of Matrix metalloproteinases in serumof patients with melanoma: snarled intechnical pitfalls. Commentary on Nikkola et al., p. 5158. Clin Cancer Res 2005, 11:5069-5070.
23. Baker A.H., Edwards D.R., Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 2002, 115:3719-3727.
24. Jiang Y., Wang M., Celiker M., Liu Y., Sang Q., Goldberg I., et al. Stimulation of mammary tumorigenesis by systemic inhibitor of matrix metalloproteinase 4 gene delivery. Cancer Res 2001, 61:2365-2370.
25. Baker A.H., George S.J., Zaltsman A.B., Murphy G., Newby A.C. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br J Cancer 1999, 79:1347-1355.
26. Smith M.R., Kung H.F., Durum S.K., Colburn N.H., Sun Y. TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. Cytokine 1997, 9:770-778.
27. Sarén P., Welgus H.G., Kovanen P.T. TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996, 157:4159-4165.
28. Jalapathy K.V., Prabha C., Das S.D. Correlates of protective immune response in tuberculous pleuritis. FEMS Immunol Med Microbiol 2004, 40:139-145.
29. Rajavelu P., Pokkali S., Bhatt K., Narayanan P.R., Salgame P., Das S.D. Comparative evaluation of cytokines, T-cell apoptosis, and costimulatory molecule expression in tuberculous and nontuberculous pleurisy. Clin Transl Sci 2008, 1:209-214.
30. Prabha C., Jalapathy K.V., Matsa R.P., Das S.D. Differential T helper cell response in tuberculous pleuritis. Indian J Med Microbiol 2007, 25:3-18.
31. Koshimoto T., Akira S., Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science 1992, 258:22-26.
32. Lotz M., Guerne P.A. Interleukin-6 induces the synthesis of tissue inhibitor metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 1991, 266:2017-2019.
33. Łukaszewicz-Zajac M., Mroczko B., Kozłowski M., Nikliński J., Laudański J., Szmitkowski M. Elevated levels of serum metalloproteinase 9 in patients with esophageal squamous cell carcinoma. Pol Arch Med Wewn 2009, 119:558-563.
34. Hoffmann U., Bertsch T., Dvortsak E., Liebetrau C., Lang S., Liebe V., Huhle G., Borggrefe M., Brueckmann M. Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis. Scand J Infect Dis 2006, 38:867-872.
35. Gäddnäs F.P., Sutinen M.M., Koskela M., Tervahartiala T., Sorsa T., Salo T.A., Laurila J.J., Koivukangas V., Ala-Kokko T.I., Oikarinen A. Matrix-metalloproteinase-2, -8 and -9 in serum and skin blister fluid in patients with severe sepsis. Crit Care 2010, 14:R49.
36. Chang C., Wysocki A., Tchou-Wong K.M., Moskowitz N., Zhang Y., Rom W.N. Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. Thorax 1996, 51:306-311.